Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy Trial of Danazol in Patients With Fanconi Anemia or Dyskeratosis Congenita

This study has been terminated.
(Study was terminated due to under enrollment)
Sponsor:
Information provided by (Responsible Party):
Colin Sieff, Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT01001598
First received: October 22, 2009
Last updated: September 12, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2014
  Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)